HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes

Rita Shaknovich, Maria Figueroa, Ari Melnick

Research output: Chapter in Book/Report/Conference proceedingChapter

20 Citations (Scopus)

Abstract

The role of cytosine methylation in the regulation of gene expression during normal development and malignant transformation is currently under intense investigation. An ever increasing body of evidence demonstrates that carcinogenesis is associated with aberrant DNA methylation of the promoters of tumor suppressor genes (Chin Med J (Engl) 111:1028-1030, 1998; Leukemia 17:2533-2535, 2003), hypomethylation of oncogenes (Toxicol Appl Pharmacol 206:288-298, 2005; Toxicology 50:231-245, 1988), and concurrent loss of methylation in the intergenic areas and gene bodies, which may lead to genomic instability and chromosomal fragility (Cytogenet Cell Genet 89:121-128, 2000). Single locus methylation assays have focused largely on specific known tumor suppressor genes or oncogenes (Chin Med J (Engl) 111:1028-1030, 1998; Cancer Res 57:594-599, 1997; Hum Genet 94:491-496, 1994; Mol Cell Biol 14:4225-4232, 1994; Gastroenterology 116:394-400, 1999). Such approaches, while being useful, have clear limitations. With the advent of genome-wide microarray-based techniques, it has become possible to perform genome-wide exploratory studies to better understand genomic patterning of DNA methylation and also to discover new potential disease-specific epigenetic lesions (J Cell Biochem 88:138-143, 2003; Genome Res 16:1075-1083, 2006). In order to capture this type of information from primary human tissues, we have adopted and optimized the HELP assay (HpaII tiny fragment Enrichment by Ligation-mediated PCR) to compare and contrast the abundance of cytosine methylation of genomic regions that are relatively enriched for CpG dinucleotides. While we have mainly used a custom NimbleGen-Roche high-density oligonucleotide microarray containing 25,626 HpaII amplifiable fragments, many other microarray platforms or high throughput sequencing strategies can be used with HELP.

Original languageEnglish (US)
Title of host publicationMicroarray Methods for Drug Discovery
EditorsSridar V. Chittur
Pages191-201
Number of pages11
DOIs
StatePublished - Dec 1 2010
Externally publishedYes

Publication series

NameMethods in Molecular Biology
Volume632
ISSN (Print)1064-3745

Fingerprint

Methylation
Ligation
Lymphocytes
Viverridae
Chin
Cytosine
Genome
DNA Methylation
Tumor Suppressor Genes
Oncogenes
Chromosome Fragility
Genomic Instability
Gene Expression Regulation
Gastroenterology
Oligonucleotide Array Sequence Analysis
Epigenomics
Toxicology
Carcinogenesis
Leukemia
Polymerase Chain Reaction

Keywords

  • DNA methylation
  • Epigenomics
  • Gene regulation
  • Genomic microarray
  • HELP assay

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Shaknovich, R., Figueroa, M., & Melnick, A. (2010). HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes. In S. V. Chittur (Ed.), Microarray Methods for Drug Discovery (pp. 191-201). (Methods in Molecular Biology; Vol. 632). https://doi.org/10.1007/978-1-60761-663-4_12

HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes. / Shaknovich, Rita; Figueroa, Maria; Melnick, Ari.

Microarray Methods for Drug Discovery. ed. / Sridar V. Chittur. 2010. p. 191-201 (Methods in Molecular Biology; Vol. 632).

Research output: Chapter in Book/Report/Conference proceedingChapter

Shaknovich, R, Figueroa, M & Melnick, A 2010, HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes. in SV Chittur (ed.), Microarray Methods for Drug Discovery. Methods in Molecular Biology, vol. 632, pp. 191-201. https://doi.org/10.1007/978-1-60761-663-4_12
Shaknovich R, Figueroa M, Melnick A. HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes. In Chittur SV, editor, Microarray Methods for Drug Discovery. 2010. p. 191-201. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-60761-663-4_12
Shaknovich, Rita ; Figueroa, Maria ; Melnick, Ari. / HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes. Microarray Methods for Drug Discovery. editor / Sridar V. Chittur. 2010. pp. 191-201 (Methods in Molecular Biology).
@inbook{f8adc936d92041f9b9a2a0014bb64607,
title = "HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes",
abstract = "The role of cytosine methylation in the regulation of gene expression during normal development and malignant transformation is currently under intense investigation. An ever increasing body of evidence demonstrates that carcinogenesis is associated with aberrant DNA methylation of the promoters of tumor suppressor genes (Chin Med J (Engl) 111:1028-1030, 1998; Leukemia 17:2533-2535, 2003), hypomethylation of oncogenes (Toxicol Appl Pharmacol 206:288-298, 2005; Toxicology 50:231-245, 1988), and concurrent loss of methylation in the intergenic areas and gene bodies, which may lead to genomic instability and chromosomal fragility (Cytogenet Cell Genet 89:121-128, 2000). Single locus methylation assays have focused largely on specific known tumor suppressor genes or oncogenes (Chin Med J (Engl) 111:1028-1030, 1998; Cancer Res 57:594-599, 1997; Hum Genet 94:491-496, 1994; Mol Cell Biol 14:4225-4232, 1994; Gastroenterology 116:394-400, 1999). Such approaches, while being useful, have clear limitations. With the advent of genome-wide microarray-based techniques, it has become possible to perform genome-wide exploratory studies to better understand genomic patterning of DNA methylation and also to discover new potential disease-specific epigenetic lesions (J Cell Biochem 88:138-143, 2003; Genome Res 16:1075-1083, 2006). In order to capture this type of information from primary human tissues, we have adopted and optimized the HELP assay (HpaII tiny fragment Enrichment by Ligation-mediated PCR) to compare and contrast the abundance of cytosine methylation of genomic regions that are relatively enriched for CpG dinucleotides. While we have mainly used a custom NimbleGen-Roche high-density oligonucleotide microarray containing 25,626 HpaII amplifiable fragments, many other microarray platforms or high throughput sequencing strategies can be used with HELP.",
keywords = "DNA methylation, Epigenomics, Gene regulation, Genomic microarray, HELP assay",
author = "Rita Shaknovich and Maria Figueroa and Ari Melnick",
year = "2010",
month = "12",
day = "1",
doi = "10.1007/978-1-60761-663-4_12",
language = "English (US)",
isbn = "9781607616627",
series = "Methods in Molecular Biology",
pages = "191--201",
editor = "Chittur, {Sridar V.}",
booktitle = "Microarray Methods for Drug Discovery",

}

TY - CHAP

T1 - HELP (HpaII tiny fragment enrichment by ligation-mediated pcr) assay for dna methylation profiling of primary normal and malignant b lymphocytes

AU - Shaknovich, Rita

AU - Figueroa, Maria

AU - Melnick, Ari

PY - 2010/12/1

Y1 - 2010/12/1

N2 - The role of cytosine methylation in the regulation of gene expression during normal development and malignant transformation is currently under intense investigation. An ever increasing body of evidence demonstrates that carcinogenesis is associated with aberrant DNA methylation of the promoters of tumor suppressor genes (Chin Med J (Engl) 111:1028-1030, 1998; Leukemia 17:2533-2535, 2003), hypomethylation of oncogenes (Toxicol Appl Pharmacol 206:288-298, 2005; Toxicology 50:231-245, 1988), and concurrent loss of methylation in the intergenic areas and gene bodies, which may lead to genomic instability and chromosomal fragility (Cytogenet Cell Genet 89:121-128, 2000). Single locus methylation assays have focused largely on specific known tumor suppressor genes or oncogenes (Chin Med J (Engl) 111:1028-1030, 1998; Cancer Res 57:594-599, 1997; Hum Genet 94:491-496, 1994; Mol Cell Biol 14:4225-4232, 1994; Gastroenterology 116:394-400, 1999). Such approaches, while being useful, have clear limitations. With the advent of genome-wide microarray-based techniques, it has become possible to perform genome-wide exploratory studies to better understand genomic patterning of DNA methylation and also to discover new potential disease-specific epigenetic lesions (J Cell Biochem 88:138-143, 2003; Genome Res 16:1075-1083, 2006). In order to capture this type of information from primary human tissues, we have adopted and optimized the HELP assay (HpaII tiny fragment Enrichment by Ligation-mediated PCR) to compare and contrast the abundance of cytosine methylation of genomic regions that are relatively enriched for CpG dinucleotides. While we have mainly used a custom NimbleGen-Roche high-density oligonucleotide microarray containing 25,626 HpaII amplifiable fragments, many other microarray platforms or high throughput sequencing strategies can be used with HELP.

AB - The role of cytosine methylation in the regulation of gene expression during normal development and malignant transformation is currently under intense investigation. An ever increasing body of evidence demonstrates that carcinogenesis is associated with aberrant DNA methylation of the promoters of tumor suppressor genes (Chin Med J (Engl) 111:1028-1030, 1998; Leukemia 17:2533-2535, 2003), hypomethylation of oncogenes (Toxicol Appl Pharmacol 206:288-298, 2005; Toxicology 50:231-245, 1988), and concurrent loss of methylation in the intergenic areas and gene bodies, which may lead to genomic instability and chromosomal fragility (Cytogenet Cell Genet 89:121-128, 2000). Single locus methylation assays have focused largely on specific known tumor suppressor genes or oncogenes (Chin Med J (Engl) 111:1028-1030, 1998; Cancer Res 57:594-599, 1997; Hum Genet 94:491-496, 1994; Mol Cell Biol 14:4225-4232, 1994; Gastroenterology 116:394-400, 1999). Such approaches, while being useful, have clear limitations. With the advent of genome-wide microarray-based techniques, it has become possible to perform genome-wide exploratory studies to better understand genomic patterning of DNA methylation and also to discover new potential disease-specific epigenetic lesions (J Cell Biochem 88:138-143, 2003; Genome Res 16:1075-1083, 2006). In order to capture this type of information from primary human tissues, we have adopted and optimized the HELP assay (HpaII tiny fragment Enrichment by Ligation-mediated PCR) to compare and contrast the abundance of cytosine methylation of genomic regions that are relatively enriched for CpG dinucleotides. While we have mainly used a custom NimbleGen-Roche high-density oligonucleotide microarray containing 25,626 HpaII amplifiable fragments, many other microarray platforms or high throughput sequencing strategies can be used with HELP.

KW - DNA methylation

KW - Epigenomics

KW - Gene regulation

KW - Genomic microarray

KW - HELP assay

UR - http://www.scopus.com/inward/record.url?scp=77953253061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953253061&partnerID=8YFLogxK

U2 - 10.1007/978-1-60761-663-4_12

DO - 10.1007/978-1-60761-663-4_12

M3 - Chapter

SN - 9781607616627

T3 - Methods in Molecular Biology

SP - 191

EP - 201

BT - Microarray Methods for Drug Discovery

A2 - Chittur, Sridar V.

ER -